34th Annual General Meeting Details
The 34th Annual General Meeting (AGM) of Sun Pharmaceutical Industries Limited is scheduled to be held on Friday, 31 July 2026, at 4:00 p.m. (IST) through Video Conferencing (VC).
The Notice convening the AGM and the Annual Report for the financial year 2025-26 will be dispatched to shareholders in due course, in compliance with relevant statutory requirements.
Shareholders are requested to ensure their latest contact details (including email IDs and addresses) are updated with their Depository Participants (for shares in dematerialized form) or with the Company's Registrar and Transfer Agent - RTA (for shares in physical form) to facilitate timely delivery of the Annual Report, AGM Notice, and credit of dividend.
Final Dividend for FY 2025-26
The payment of the final dividend, if approved by the shareholders at the AGM, will be made on or before Friday, 07 August 2026.
TDS on Dividend Requirements
Dividend shall be subject to deduction of tax at source at applicable rates. Shareholders may refer to the TDS guidance and document submission process available on the Company's website (www.sunpharma.com) or through the provided QR code.
Requisite documents, if any, should be submitted on or before Tuesday, 07 July 2026 to enable application of the appropriate TDS rate.